Lv1
40 积分 2023-12-02 加入
The FGF–FGFR axis as an immune–metabolic rheostat in gastrointestinal inflammation and cancer
1小时前
待确认
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma
2小时前
已完结
Tumor microenvironment and metabolic reprogramming in MASLD-related hepatocellular carcinoma
2小时前
求助中
Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease
27天前
已完结
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
3个月前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
4个月前
已完结
Regulated necrosis at the crossroads of liver inflammation and cancer development
5个月前
已完结
The origin of hepatocellular carcinoma depends on metabolic zonation
5个月前
已完结
Improving surgical treatments for hepatocellular carcinoma
5个月前
已完结
Integrated therapies for targeting the microenvironment of hepatocellular carcinoma
5个月前
已完结
皖公网安备34019202002308
